WikiPatents - Community Patent Review
Create Free Account  |  License or Sell Your Patent  |  WikiPatents Marketplace  |  WikiPatents Blog
Username:  Password:  
    
Advanced Search
Electromagnetic method and apparatus to measure constituents of human or animal tissue    
United States Patent5183042   
Link to this pagehttp://www.wikipatents.com/5183042.html
Inventor(s)Harjunmaa; Hannu (Holden, MA); Mendelson; Yitzhak (Worcester, MA); Wang; Yi (Worcester, MA)
AbstractTo deterine glucose or other constituents of the human or animal body, near-infrared radiation containing two alternating wavelengths that have equal extinction coefficients in the tissue is directed onto a sample area of the body. The intensity relation of the two different wavelengths is adjusted so as to balance the two wavelength detected signals. The extracellular-to-intracellular fluid ratio of the tissue is changed or is allowed to change, and the alternating component of the transmitted beam power is measured. The amplitude of the alternating-current (AC) signal given by the detector represents glucose concentration or the difference from a preset reference concentration.



 Title Information Submit all comments and votes
 
Patent Text Patent PDF Print Page Summary File History
Plain text PDF images Print Summary File History
Drawing from US Patent 5183042
Electromagnetic method and apparatus to measure constituents of human or

     animal tissue - US Patent 5183042 Drawing
Electromagnetic method and apparatus to measure constituents of human or animal tissue
Inventor     Harjunmaa; Hannu (Holden, MA); Mendelson; Yitzhak (Worcester, MA); Wang; Yi (Worcester, MA)
Owner/Assignee     Vivascan Corporation (Southboro, MA)
Patent assignment
All assignments
Publication Date     February 2, 1993
Application Number     07/725,502
PAIR File History     Application Data   Transaction History
Image File Wrapper   Patent Term   Fees
Litigation
Filing Date     July 3, 1991
US Classification     600/309 356/39 600/316 600/473
Int'l Classification     A61B 005/00 G01N 021/59
Examiner     Cohen; Lee S.
Assistant Examiner     Pontius; Kevin
Attorney/Law Firm     Hamilton, Brook, Smith & Reynolds
Address
Parent Case     RELATED APPLICATIONS This is a continuation-in-part of co-pending application U.S. Ser. No. 07/527,514 filed May 23, 1990, now U.S. Pat. No. 5,099,123 entitled "Method for Determining by Absorption of Radiations the Concentration of Substances in Absorbing and Turbid Matrices" claiming priority to EPA 89810382.5 filed May 23, 1989, and U.S. Ser. No. 07/511,229 filed Apr. 19, 1990, now U.S. Pat. No. 5,137,023 entitled "Method and Apparatus for Monitoring Blood Analytes Noninvasively by Pulsatile Photoplethysmography", and U.S. Ser. No. 07/511,341 filed Apr. 19, 1990, now U.S. Pat. No. 5,112,124 entitled "Measuring the Concentration of Absorbing Substances". Also, a U.S. patent application 5,178,142 entitled "Electromagnetic Method and Apparatus to Measure Constituents of Human or Animal Tissue" has been filed concurrent with this application. All of the above-referenced patent applications are hereby incorporated by reference.
Priority Data     May 23, 1989[EP]89810382.5
USPTO Field of Search     128/633 128/634 128/664 356/41 356/39 250/339 250/341 250/351 250/352
Patent Tags     electromagnetic measure constituents human or animal tissue
   
Enter a comma (,) or semicolon (;) between multiple tag words/phrases.
Describe this patent:
 Amusing   
 Clever   
 Complex   
 Efficient   
 Historic   
 Important   
 Innovative   
 Interesting   
 Practical   
 Simple   
[no votes]
Patent WIKI

Share information and news about this patent, including information and news about the technology, inventors, company, ligation and licensing.

 References Submit all comments and votes
 
*references marked with an asterisk below are user-added references
 U.S. References
 
Add a new US reference:  
ReferenceRelevancyCommentsReferenceRelevancyComments
1758088



[0 after 0 votes]
2721942



[0 after 0 votes]
3463142



[0 after 0 votes]
5028787
Rosenthal
250/339.12
Jul,1991

[0 after 0 votes]
4882492
Schlager
250/346
Nov,1989

[0 after 0 votes]
4863265
Flower
356/41
Sep,1989

[0 after 0 votes]
4832484
Aoyagi
356/41
May,1989

[0 after 0 votes]
4817623
Stoddart
600/477
Apr,1989

[0 after 0 votes]
4805623
Jobsis
600/328
Feb,1989

[0 after 0 votes]
4796636
Branstetter
600/330
Jan,1989

[0 after 0 votes]
4759369
Taylor
600/323
Jul,1988

[0 after 0 votes]
4750496
Reinhart
600/347
Jun,1988

[0 after 0 votes]
4725147
Stoddart
356/433
Feb,1988

[0 after 0 votes]
4704029
Van Heuvelen
356/39
Nov,1987

[0 after 0 votes]
4655225
Dahne
600/316
Apr,1987

[0 after 0 votes]
4653498
New, Jr.
600/324
Mar,1987

[0 after 0 votes]
4621643
New, Jr.
600/331
Nov,1986

[0 after 0 votes]
4603700
Nichols
600/331
Aug,1986

[0 after 0 votes]
4586513
Hamaguri
600/326
May,1986

[0 after 0 votes]
4570638
Stoddart
600/476
Feb,1986

[0 after 0 votes]
4513751
Abe
600/479
Apr,1985

[0 after 0 votes]
4490845
Steinbruegge
356/300
Dec,1984

[0 after 0 votes]
4485820
Flower
600/320
Dec,1984

[0 after 0 votes]
4427889
Muller
250/339.11
Jan,1984

[0 after 0 votes]
4398541
Pugliese
600/476
Aug,1983

[0 after 0 votes]
4380240
Jobsis
600/344
Apr,1983

[0 after 0 votes]
4306877
Lubbers
436/166
Dec,1981

[0 after 0 votes]
4267844
Yamanishi
600/315
May,1981

[0 after 0 votes]
4266554
Hamaguri
600/323
May,1981

[0 after 0 votes]
4169676
Kaiser
356/39
Oct,1979

[0 after 0 votes]
4033330
Willis
600/366
Jul,1977

[0 after 0 votes]
4029085
DeWitt
600/315
Jun,1977

[0 after 0 votes]
3963019
Quandt
600/319
Jun,1976

[0 after 0 votes]
3958560
March
600/319
May,1976

[0 after 0 votes]
3926527
Pembrook
356/246
Dec,1975

[0 after 0 votes]
3638640
Shaw
600/323
Feb,1972

[0 after 0 votes]
3614450
Hill
700/68
Oct,1971

[0 after 0 votes]
4768516
Stoddart
600/474
Dec,1969

[0 after 0 votes]
4321930
Jobsis
600/344
Dec,1969

[0 after 0 votes]
 Foreign References
 Other References
 Market Review Submit all comments and votes
   
Market Size
Estimate the gross annual revenues of the relevant market sector:
> $10B
$5B - $10B
$2B - $5B
$500M - $2B
$100M - $500M
$10M - $100M
$1M - $10M
$500K - $1M
$100K - $500K
< $100K
[No votes]
$0
 
$0   $2.5B   $5B   $7.5B   $10B
Market Share
Estimate the percentage of the relevant market sector this invention will capture:
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%
Reasonable Royalty
What percentage of gross sales should the inventor or assignee be paid?
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%
Public's "Guesstimation" of Royalty Value
Market SizeN/A[No votes]
xMarket ShareN/A[No votes]
xReasonable RoyaltyN/A[No votes]

N/A

License Availablity
If you are NOT the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
License Availablity
If you ARE the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
Competitive Advantage
Does this invention have a significant competitive advantage over similar technologies?
Yes

No



[No votes]
Most helpful competitive advantage comment
[No comments]

Commercial Alternatives
Are there viable commercial alternatives for this invention?
Yes

No



[No votes]
Most helpful commercial alternative comment
[No comments]

 Technical Review Submit all comments and votes
 Claims Submit all comments and votes
 


We claim:

1. A non-invasive method for measuring the concentration of analytes in living tissue containing fluids, comprising the steps of:

a) illuminating the tissue with an electromagnetic beam comprised of alternate periods of monochromatic wavelengths, one of the alternate periods having a wavelength that is absorbed by the analyte, and the other alternate period having a wavelength selected so as to have an extinction coefficient in the tissue identical with that of the first wavelength;

b) detecting the electromagnetic beam after reaction with the tissue to produce a first electrical signal;

c) adjusting the intensity relation between wavelength periods of the illuminating beam so as to produce a substantially zero alternating component in the first electrical signal;

d) varying the balance of analyte present in the tissue; and

e) detecting an alternating component of the beam that has interacted with the tissue to generate a second electrical signal proportional to the concentration of analyte in the tissue; and

f) calculating the concentration of the analyte in the tissue.

2. The method according to claim 1 where the residual amplitude of the alternating component, if there is any remaining after step (c), is recorded and used to calculate the concentration of the analyte.

3. The method according to claim 1 wherein varying the balance of analyte includes changing tissue thickness.

4. The method according to claim 3 wherein the tissue thickness change is substantially equal to the inverse of the extinction coefficient of the tissue at the wavelengths used.

5. The method according to claim 4 wherein the tissue thickness change is repeated cyclically, and the second electrical signal variation over the cycle is used as a measure of the concentration of the analyte in blood.

6. The method according to claim 1 wherein varying the balance of analyte is accomplished by the normal pulsatile cycle produced by the heart beat.

7. The method according to claim 1, whereby, before illuminating the sample with the electromagnetic beam, the tissue is illuminated by a radiation transmitting means with a pulsed beam containing only one of the two alternating wavelengths, and the radiation that has interacted with the sample is detected with a radiation detecting means to produce a third electrical signal.

8. The method according to claim 7 whereby at the beginning of the measurement, the thickness of the tissue between the radiation transmitting means and the radiation detecting means is decreased gradually until the amplitude of the transmitted radiation pulse train attains a predetermined value.

9. The method according to claim 7 whereby the third electrical signal is recorded and the second electrical signal obtained in step e) of claim 1 is normalized by dividing it by the third electrical signal.

10. The method according to claim 1 wherein the electromagnetic beam traverses the tissue.

11. The method according to claim 1 wherein the electromagnetic beam is reflected from the tissue.

12. The method according to claim 1 wherein the analyte is a heterologous material.

13. The method according to claim 1 wherein the analyte is a homologous material.

14. The method of claim 1 wherein the analyte is glucose and the alternate wavelengths are 2155 nm and 2272 nm.

15. A non-invasive apparatus for measuring the concentration of analytes in a living tissue, comprising:

a) a source of electromagnetic radiation for illuminating the tissue with an electromagnetic beam comprised of alternate periods of different wavelengths, one of the alternate periods having a first wavelength that is absorbed by the analyte, and the other alternate period having a wavelength selected so as to have an extinction coefficient in the tissue identical with that of said first wavelength;

b) a detector means for detecting the electromagnetic beam after reaction with the tissue to produce a first electrical signal proportional to the intensity of said electromagnetic beam; and

c) intensity control means for adjusting the intensity relation between wavelength periods of the illuminating beam so as to produce, a reference level component in the first electrical signal when a minimum level of analyte is present in the tissue;

d) whereby the first electrical signal when analyte is present is proportional to the concentration of analyte in the tissue.

16. The apparatus according to claim 15 wherein the radiation source comprises a master source and a slave source, each generating a beam of light which beams are combined to form said alternating periods of different wavelengths.

17. The apparatus according to claim 16 wherein the master source and slave source comprise incandescent lamps with filters for passing monochromatic light of different wavelengths .lambda..sub.1 and .lambda..sub.2.

18. The apparatus of claim 17 wherein .lambda..sub.1 is 2155 nm and .lambda..sub.2 is 2272 nm and the analyte is glucose.

19. The apparatus of claim 15 including means for changing tissue thickness to produce the minimal level of analyte in the tissue.

20. The apparatus according to claim 19 wherein the tissue thickness change is substantially equal to the inverse of the extinction coefficient of the tissue at the wavelengths used.

21. A non-invasive apparatus for measuring the concentration of analytes in a living tissue, comprising:

a) a source of electromagnetic radiation for illuminating the tissue with an electromagnetic beam comprised of alternate periods of different wavelengths, one of the alternate periods having a first wavelength that is absorbed by the analyte, and the other alternate period having a wavelength selected so as to have an extinction coefficient in the tissue identical with that of said first wavelength;

b) a detector means for detecting the electromagnetic beam after reaction with the tissue to produce a first electrical signal proportional to the intensity of said electromagnetic beam; and

c) analyte level changing means for changing the level of analyte in the tissue;

d) intensity control means for adjusting the intensity relation between wavelength periods of the illuminating beam so as to produce, a reference level component in the first electrical signal when a minimum level of analyte is present in the tissue whereby the first electrical signal when analyte is present is proportional to the concentration of analyte in the tissue;

e) temperature control means for maintaining the temperature of the tissue substantially constant during measurement.

22. The apparatus according to claim 21 wherein the radiation source comprises a master source and a slave source, each generating a beam of light which beams are combined to form said alternating periods of different wavelengths and fiber optic means for transmitting the combined beam to the tissue.

23. The apparatus according to claim 22 wherein the master source and slave source comprise incandescent lamps with filters for passing monochromatic light of different wavelengths .lambda..sub.1 and .lambda..sub.2.

24. The apparatus of claim 23 wherein .lambda..sub.1 is 2155 nm and .lambda..sub.2 is 2272 nm and the analyte is glucose.

25. The apparatus of claim 21 wherein the analyte level changing means includes means for changing tissue thickness to produce the change in level of analyte in the tissue.

26. The apparatus of claim 21 wherein the temperature control means includes a pair of oppositely disposed thermally conductive bodies disposed opposite each other with a variable gap between them, into which gap the tissue is adapted to be placed and wherein the temperature of the bodies is sensed and controlled.

27. The apparatus of claim 26 including an opening through said bodies for passing the radiation beam through the tissue for detection.

28. The apparatus of claim 27 wherein the analyte level changing means comprises actuator means for moving one body relative to the other to squeeze said tissue.
 Description Submit all comments and votes
 


BACKGROUND OF THE INVENTION

This invention relates to the non-invasive measurement of the concentration of substances that absorb electromagnetic radiation, such as light or infrared radiation, in absorbing and turbid matrices, such as human or animal body tissue, using a probe beam of electromagnetic radiation. The invention is described as applied to the special case of glucose measurement in human tissue using near-infrared radiation. It is, however, generally applicable to measurements of the concentration of any species that absorbs electromagnetic radiation, especially in strongly absorbing and turbid matrices.

The infrared measurement methods known in the art are not well adapted to the problem of quantifying an analyte dissolved in a strongly absorbing solvent. The known methods include separate or directly alternating measurements at a "glucose" wavelength and at a "reference"wavelength, where glucose does not absorb, as well as differential wavelength modulation about a glucose absorption band (C. Dahne, D. Gross, European Pat. No. 0 160 768 and references therein). In the known methods, the signal is easily lost into the variable and strong background presented by water and other constituents in the tissue and in the capillary blood flow.

SUMMARY OF THE INVENTION

The present invention is an improvement over copending European patent application No. 9810382.5 (Harjunmaa), U.S. Ser. No. 07/527,514 referenced above. In Harjunmaa, a balanced differential modulation method is disclosed wherein a radiation beam comprised of alternating pulses of two wavelengths forming a combined beam, is balanced or nulled using a reference detector that takes a sample of the combined beam before it enters the tissue and is detected by a primary detector. Although suitable for the purposes intended, the precautions taken to deal with the unavoidable differences in the spectral response between the reference detector and the primary detector make the system somewhat complicated.

The balanced differential (or balanced bridge) method of Harjunmaa utilizes two wavelengths that have the special property of having identical extinction coefficients in the sample matrix. A radiation beam is generated that contains these two wavelengths in alternate succession at a suitable frequency. When the beam is properly balanced for the measurement, a detector placed to detect the radiation beam does not detect any alternating component in the radiation. When the sample is inserted into the beam path, the same detector also would detect no alternating component, if the matrix did not contain any of the analytes. Only in the case where there is some analyte in the sample matrix will the detector detect an alternating signal synchronous with the wavelength